These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 146752)

  • 1. Tetanus toxoid boosters.
    Rothstein RJ
    JAMA; 1978 Mar; 239(12):1133. PubMed ID: 146752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arm swelling and local skin reaction after Di-Te vaccination. 2 case reports].
    Thierfelder C; Flückiger U
    Praxis (Bern 1994); 2004 Nov; 93(46):1929-31. PubMed ID: 15580886
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypersensitivity to tetanus toxoid.
    Facktor MA; Bernstein RA; Fireman P
    J Allergy Clin Immunol; 1973 Jul; 52(1):1-12. PubMed ID: 4268453
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on untoward reactions to diphtheria and tetanus toxoids.
    Relyveld EH; Henocq E; Bizzini B
    Dev Biol Stand; 1979; 43():33-7. PubMed ID: 160349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity against tetanus 3 years after revaccination].
    Bozović M; Pavlović V
    Med Pregl; 1991; 44(1-2):77-8. PubMed ID: 1870472
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults.
    Myers MG; Beckman CW; Vosdingh RA; Hankins WA
    JAMA; 1982 Nov; 248(19):2478-80. PubMed ID: 7131703
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?
    Posfay-Barbe KM; Kobela M; Sottas C; Grillet S; Taguebue J; Ekoe T; Lambert PH; Lecoultre C; Siegrist CA
    Vaccine; 2010 Jun; 28(27):4356-61. PubMed ID: 20447475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to tetanus toxoid.
    Jacobs RL; Lowe RS; Lanier BQ
    JAMA; 1982 Jan; 247(1):40-2. PubMed ID: 7053439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine.
    Nolan T; Richmond P; Marshall H; McVernon J; Alexander K; Mesaros N; Aris E; Miller J; Poolman J; Boutriau D
    Pediatr Infect Dis J; 2011 Mar; 30(3):190-6. PubMed ID: 20948453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in anti-tetanus antibodies under sero-toxoid therapy. Study in 50 patients with tetanus].
    Goulon M; Girard O; Grosbuis S; Desormeau JP; Capponi MF
    Nouv Presse Med; 1976 Mar; 5(13):847-50. PubMed ID: 1264625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitetanus vaccination and neonatal protection in developing countries.
    Relyveld EH; Labusquière R; Gateff C; Le Bourthe F; Ravisse P; Lemarinier G; Chambon L
    Prog Immunobiol Stand; 1971; 5():517-27. PubMed ID: 4676690
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immune response after revaccination with tetanus anatoxin in persons over 60 years of age].
    Masár I; Kamenická L; Nováková I; Borská K; Palanová A
    Cesk Epidemiol Mikrobiol Imunol; 1986 Jul; 35(4):211-6. PubMed ID: 2942264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of reduced doses of diphtheria-tetanus toxoid for revaccination of children with changed reactivity].
    Braginskaia VP; Shabad AT; Manvelova MA; Aleksina SG; Podshivalova VA
    Vopr Okhr Materin Det; 1974 Feb; 19(2):65-9. PubMed ID: 4468507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of hyperimmunization against tetanus and systematic adverse reactions to tetanus toxoid in children].
    Szenborn L; Saraczyńska E; Ilnicki L
    Med Wieku Rozwoj; 2008; 12(2 Pt 2):699-704. PubMed ID: 19418947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive use of tetanus toxoid boosters.
    Edsall G; Elliott MW; Peebles TC; Eldred MC
    JAMA; 1967 Oct; 202(1):111-3. PubMed ID: 6071998
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate local reaction to tetanus toxoid booster.
    Piletta PA; Pasche-Koo F; Saurat JH; Hauser C
    Allergy; 1997 Jun; 52(6):676-7. PubMed ID: 9226067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines for the use of antitetanus vaccination].
    Ribero ML; Volpato C
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):550-3. PubMed ID: 7248089
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local reactions after repeated tetanus vaccinations].
    Wegmann A; Heiz R
    Schweiz Med Wochenschr; 1979 Oct; 109(38):1409-10. PubMed ID: 531542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.